Critical pathways in cellular senescence and immortalization revealed by gene expression profiling

被引:258
作者
Fridman, A. L.
Tainsky, M. A. [1 ]
机构
[1] Wayne State Univ, Sch Med, Program Mol Biol & Genet, Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA
关键词
immortalization; senescence; cell cycle; interferon; cytoskeletal; IGF-related genes;
D O I
10.1038/onc.2008.213
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bypassing cellular senescence and becoming immortal is a prerequisite step in the tumorigenic transformation of a cell. It has long been known that loss of a key tumor suppressor gene, such as p53, is necessary, but not sufficient, for spontaneous cellular immortalization. Therefore, there must be additional mutations and/or epigenetic alterations required for immortalization to occur. Early work on these processes included somatic cell genetic studies to estimate the number of senescence genes, and microcell-mediated transfer of chromosomes into immortalized cells to identify putative senescence-inducing genetic loci. These principal studies laid the foundation for the field of senescence/immortalization, but were labor intensive and the results were somewhat limited. The advent of gene expression pro. ling and bioinformatics analysis greatly facilitated the identification of genes and pathways that regulate cellular senescence/ immortalization. In this review, we present the findings of several gene expression pro. ling studies and supporting functional data, where available. We identified universal genes regulating senescence/ immortalization and found that the key regulator genes represented six pathways: the cell cycle pRB/p53, cytoskeletal, interferon-related, insulin growth factor-related, MAP kinase and oxidative stress pathway. The identification of the genes and pathways regulating senescence/ immortalization could provide novel molecular targets for the treatment and/or prevention of cancer.
引用
收藏
页码:5975 / 5987
页数:13
相关论文
共 130 条
[1]  
Bachinski LL, 2005, CANCER RES, V65, P427
[2]   Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer [J].
Baylin, SB ;
Esteller, M ;
Rountree, MR ;
Bachman, KE ;
Schuebel, K ;
Herman, JG .
HUMAN MOLECULAR GENETICS, 2001, 10 (07) :687-692
[3]   DNA hypermethylation in tumorigenesis - epigenetics joins genetics [J].
Baylin, SB ;
Herman, JG .
TRENDS IN GENETICS, 2000, 16 (04) :168-174
[4]   Identification of novel candidates for replicative senescence by functional proteomics [J].
Benvenuti, S ;
Cramer, R ;
Bruce, J ;
Waterfield, MD ;
Jat, PS .
ONCOGENE, 2002, 21 (28) :4403-4413
[5]   Differential proteome analysis of replicative senescence in rat embryo fibroblasts [J].
Benvenuti, S ;
Cramer, R ;
Quinn, CC ;
Bruce, J ;
Zvelebil, M ;
Corless, S ;
Bond, J ;
Yang, A ;
Hockfield, S ;
Burlingame, AL ;
Waterfield, MD ;
Jat, PS .
MOLECULAR & CELLULAR PROTEOMICS, 2002, 1 (04) :280-292
[6]   ASSIGNMENT OF 2 HUMAN EPIDERMAL SQUAMOUS-CELL CARCINOMA CELL-LINES TO MORE THAN ONE COMPLEMENTATION GROUP FOR THE IMMORTAL PHENOTYPE [J].
BERRY, IJ ;
BURNS, JE ;
PARKINSON, EK .
MOLECULAR CARCINOGENESIS, 1994, 9 (03) :134-142
[7]  
Bertram MJ, 1999, MOL CELL BIOL, V19, P1479
[8]   The genetics of cellular senescence [J].
Bérubé, NG ;
Smith, JR ;
Pereira-Smith, OM .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (05) :1015-1019
[9]  
BISCHOFF FZ, 1990, CANCER RES, V50, P7979
[10]  
BISCHOFF FZ, 1991, ONCOGENE, V6, P183